VRSK
75
-2
MMM
35
2
VMC
66
3
NDAQ
52
7
HCA
57
4
CINF
53
-3
LH
58
2
PSX
47
5
AEP
61
2
INTU
72
3
NI
62
4
ORCL
67
2
BLK
63
3
FSLR
73
3
HES
67
-3
JCI
44
3
VLO
40
5
MTCH
48
-2
V
72
2
AIG
63
-2
VRSK
75
-2
MMM
35
2
VMC
66
3
NDAQ
52
7
HCA
57
4
CINF
53
-3
LH
58
2
PSX
47
5
AEP
61
2
INTU
72
3
NI
62
4
ORCL
67
2
BLK
63
3
FSLR
73
3
HES
67
-3
JCI
44
3
VLO
40
5
MTCH
48
-2
V
72
2
AIG
63
-2
Financhill
Back

Corcept Therapeutics Quote, Financials, Valuation and Earnings

Buy
81

CORT
Corcept Therapeutics

Last Price:
27.54
Seasonality Move:
8.36%

7 Day Trial

ALL ACCESS PASS

$ 7

Corcept Therapeutics Price Quote

$27.54
-0.29 (-1.04%)
(Updated: May 16, 2024 at 6:55 PM ET)

Corcept Therapeutics Key Stats

Buy
81
Corcept Therapeutics (CORT) is a Buy
Day range:
$27.63 - $28.46
52-week range:
$20.84 - $34.28
Dividend yield:
0%
P/E ratio:
29.61
P/S ratio:
5.87
P/B ratio:
5.29%
Volume:
682.5K
Avg. volume:
1.2M
1-year change:
15.67%
Market cap:
$2.9B
Revenue:
$482.4M
EPS:
$1.06

How Much Does Corcept Therapeutics Make?

Is Corcept Therapeutics Growing As A Company?

  • What Is Corcept Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.39%
  • What Is Corcept Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0.79%

Corcept Therapeutics Stock Price Performance

What Is Corcept Therapeutics 52-Week High & Low?

Corcept Therapeutics Price To Free Cash Flow

Is It Risky To Buy Corcept Therapeutics?

Is Corcept Therapeutics Cash Flow Positive?

  • What Is CORT Cash Flow From Operations?
    Cash flow from operations (TTM) is $124.8M
  • What Is Corcept Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$149.4M
  • What Is Corcept Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$125.6M

Corcept Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    CORT return on invested capital is 23.92%
  • What Is Corcept Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is 19.58%
  • What Is CORT Return On Equity?
    ROE is a measure of profitability and is 23.92%

Corcept Therapeutics Earnings Date & Stock Price

Corcept Therapeutics Competitors

Corcept Therapeutics Dividend Yield

Data Unavailable

Corcept Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 78.57% 13.64%
Revenue: 38.95% 3.97%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 43.60
Upside from Last Price: 56.67%

Major Shareholders

  • How many CORT shares are owned by institutional investors?
    119.1M CORT shares are owned by institutional investors
  • How many CORT shares are owned by insiders?
    8.3M CORT shares are owned by insiders